QUALITY OF LIFE INDICATORS FOR THE PATIENTS WHO SUFFERED FROM COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY SARS-CoV-2

Authors

  • T. M. Homeliuk I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY
  • M. I. Marushchak I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY

DOI:

https://doi.org/10.11603/mcch.2410-681X.2023.i2.13863

Keywords:

pneumonia, COVID-19, SF-36, physical health, mental health

Abstract

Introduction. Respiratory pathology, both acute and chronic, remains one of the key problems of modern medicine in Ukraine and in the world in general, which is explained by its significant prevalence, negative impact on patients' work capacity, their quality of life, as well as the economic burden on society.

The aim of the study – to analyze the subjective state of health using the SF-36 questionnaire for patients who undergone community-acquired pneumonia caused by SARS-CoV-2 in 1 year after inpatient treatment.

Research Methods. A retrospective study of the medical records of 208 patients who had been hospitalized for non-hospital pneumonia with a negative smear test for the SARS-CoV-2 virus was conducted. The severity of pneumonia was calculated according to the PORT scale. The comparison group consisted of patients with SARS-CoV-2 nucleic acid identification and the absence. A telephone survey to assess the quality of life of the participants of the first stage of our study 1 year after discharge from the hospital were performed. The general investigator SF-36 was used to assess quality of life. Statistical analysis of data was carried out using the "STATISTICA 7.0" software.

Results and Discussion. Physical functioning according to SF-36 was the lowest in the observation group IV and probably differed in relation to the data of the observation group II and the comparison group. Analyzing the general state of health, the values were found to be probably lower for patients who suffered from community-acquired pneumonia of 3rd and 4th categories of severity compared to the data of the observation group II and the comparison group.

Conclusion. Thus, it was established low quality of life in patients after pneumonia caused by COVID-19. Practical value of the work consists in improving diagnostics and therapy, as well as improving the rehabilitation of patients who suffered from community-acquired pneumonia caused by SARS-CoV-2.

References

Malik, P., Patel, K., Pinto, C., Jaiswal, R., Tiru­pathi, R., Pillai, S., Patel, U. (2021). Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL) – A systematic review and meta-analysis. J. Med. Virol., 94, 253-262.

Poudel, A.N., Zhu, S., Cooper, N., Roderick, P., Alwan, N. (2021). Impact of Covid-19 on health-related quality of life of patients: A structured review. PLoS ONE, 10, e0259164.

Sanchez-Ramirez, D., Normand, K., Zhaoyun, Y., Torres Castro, R. (2021). Long-term impact of COVID-19: A systematic review of the literature and meta-analysis. Biomedicines, 9, 900.

Van den Borst, B., Peters, J.B., Brink, M., Schoon, Y., Bleeker-Rovers, C.P., Schers, H., van Hees, H.W.H., van Helvoort, H., van den Boogaard, M., van der Hoeven, H., et al. (2021). Comprehensive health assessment 3 months after recovery from acute Coronavirus disease 2019 (COVID-19). Clin. Infect. Dis., 73, 1089-1098.

Tarraso, J., Safont, B., Carbonell-Asins, J. (2022). Lung function and radiological findings 1 year after ­COVID-19: a prospective follow-up. Respiratory Research. DOI: 10.1186/s12931022021668,https://respiratoryresearch.biomedcentral.com/articles/10.1186/s12931-022-02166-8

Han, X., Fan, Y., Alwalid, O. (2021). Six-month follow-up chest CT findings after severe COVID-19 ­pneumonia. Radiology. https://doi.org/10.1148/radiol. 2021203153.

Pan, F., Yang, L., Liang, B (2021). Chest CT patterns from diagnosis to 1 year of follow-up in COVID-19. Radiology. https://doi.org/10.1148/radiol. 2021211199.

Wu, X., Liu, X., Zhou, Y. (2021). 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(21)00174-0.

Grassi, M., Nucera, A. (2010). Dimensionality and summary measures of the SF-36 v1.6: Comparison of scale- and item-based approach across ECRHS II adults population. Value in Health, 13, 469-478.

Sigfrid, L., Drake, T.M., Pauley, E. (2021). Long Covid in adults discharged from UK hospitals after ­COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterization. Protocol. Lancet Reg. Health Europe 8, 100186.

For the SAPRIS study group, Carrat, F., Touvier, M. (2021). Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study. BMC Infect. Dis., 21, 169.

McPeake, J., Shaw, M., MacTavish, P. (2021). Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study. BMJ Open Resp. Res., 8, e001080.

Lim, W.S. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58 (5), 377-382.

Ware, J.E., Sherbourne, C.D. (1992). The MOS 36# item short form health sur vey (SF#36). Medical Care, 30, 473-483.

Feshchenko, Yu.I., Mostovoi, Yu.M., Babii­chuk, Yu.V. (2002). The procedure for adapting the international questionnaire for assessing the quality of life in Ukraine. Experience of use in patients with bronchial asthma. Ukr. pulmonol. Journal. 3, 9-11.

Mishra, G.D., Hockey, R., & Dobson, A.J. (2014). A comparison of SF-36 summary measures of physical and mental health for women across the life course. Qual. Life Res., 23(5), 1515-1521. DOI: 10.1007/s11136-013-0586-3

Homeliuk, T.M., Marushchak, M.I. (2023). Dyna­mics of acute phase blood indicators in patients with community-acquired pneumonia caused by SARS-CoV-2. Medical and Clinical Chemistry, 25, 1, 68-74.

Chen, K.-Y., Li, T., Gong, F.-H., Zhang, J.-S., Li, X.-K. (2020). Predictors of health-related quality of life and influencing factors for COVID-19 patients, a follow-up at one month. Front Psychiatry, 11, 668.

Qu, G., Zhen, Q., Wang, W., Fan, S., Wu, Q., Zhang, C., Li, B. et al. (2021). Health-related quality of life of COVID-19 patients after discharge: A multicenter follow-up study. J. Clin. Nurs., 30, 1742-1750.

Liu, K., Zhang, W., Yang, Y., Zhang, J., Li, Y., Chen, Y. (2020). Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther. Clin. Pract. 39.

Guo, L. (2020). Correlation study of short-term mental health in patients discharged after coronavirus disease 2019 (COVID-19). Infection without comorbidities: A prospective study. Neuropsychiatr. Dis. Treat., 16, 2661-2667.

Fabbri, L., Moss, S., Khan, F.A. (2022). Pa­renchymal lung abnormalities following hospitalization for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. DOI: 10.1136/thoraxjnl-2021-218275.

Published

2023-07-11

How to Cite

Homeliuk, T. M., & Marushchak, M. I. (2023). QUALITY OF LIFE INDICATORS FOR THE PATIENTS WHO SUFFERED FROM COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY SARS-CoV-2. Medical and Clinical Chemistry, (2), 5–11. https://doi.org/10.11603/mcch.2410-681X.2023.i2.13863

Issue

Section

ORIGINAL INVESTIGATIONS